<DOC>
	<DOCNO>NCT00004096</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase I/II trial study effectiveness combine carboplatin vinorelbine treat patient stage IIIB stage IV non-small cell lung cancer .</brief_summary>
	<brief_title>Carboplatin Plus Vinorelbine Treating Patients With Stage IIIB Stage IV Non-small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine feasibility chemotherapy carboplatin vinorelbine patient stage IIIB IV non-small cell lung cancer . II . Determine maximum tolerate dose dose limit toxicity regimen patient . III . Determine response rate survival patient treatment . OUTLINE : This dose escalation study vinorelbine . Patients receive carboplatin IV 30 minute follow vinorelbine IV 6-10 minute day 1 8 . Treatment repeat every 21 day absence unacceptable toxicity disease progression . Cohorts 3-6 patient receive escalate dos vinorelbine maximum tolerate dose ( MTD ) determine . The MTD define dose 2 6 patient experience dose limit toxicity . Patients follow 1 month . PROJECTED ACCRUAL : A total 12-36 patient accrue study 6-12 month .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Vinorelbine</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Vinblastine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically proven stage IIIB IV nonsmall cell lung cancer PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : At least 8 week Hematopoietic : WBC least 3000/mm3 Absolute neutrophil count least 1500/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin great 1.5 time normal SGOT great 3 time normal Renal : Creatinine great 1.5 mg/dL OR Creatinine clearance least 50 mL/min Other : No significant active infection No severe medical illness No prior significant symptomatic peripheral neuropathy ( grade 2 worse ) No concurrent neuropathy Not pregnant nursing Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : At least 3 week since prior chemotherapy recover No 1 prior chemotherapy regimen No prior vinorelbine Endocrine therapy : Not specify Radiotherapy : Recovered prior radiotherapy No prior radiotherapy 10 % bone marrow Surgery : At least 2 week since prior major surgery recover Other : At least 30 day since prior experimental therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
</DOC>